Gemzar and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Gemzar (gemcitabine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Taxotere, and have Arthritis.

The phase IV clinical study analyzes which people have Stroke when taking Gemzar. It is created by eHealthMe based on reports of 20,184 people who have side effects when taking Gemzar from the FDA, and is updated regularly.

What is Gemzar?

Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,340 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.

On Jun, 17, 2026

20,184 people reported to have side effects when taking Gemzar.
Among them, 91 people (0.45%) have Stroke.

Among these 91 people:

How long have people been on Gemzar when they have Stroke? *

What is the gender of people who have Stroke when taking Gemzar? *

female: 54.79 %
male: 45.21 %

What is the age of people who have Stroke when taking Gemzar? *

What are other drugs people take besides Gemzar? *

Taxotere: 29 people, 31.87%
Lipitor: 28 people, 30.77%
Coumadin: 28 people, 30.77%
Aredia: 26 people, 28.57%
Celebrex: 25 people, 27.47%
Gabapentin: 25 people, 27.47%
Nexium: 25 people, 27.47%
Carboplatin: 21 people, 23.08%
Chlorhexidine Gluconate: 21 people, 23.08%
Navelbine: 20 people, 21.98%

What are other side effects people have besides Stroke? *

High Blood Pressure: 30 people, 32.97%
Anaemia (lack of blood): 29 people, 31.87%
Pain: 29 people, 31.87%
Stress And Anxiety: 29 people, 31.87%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 28 people, 30.77%
Pleural Effusion (water on the lungs): 27 people, 29.67%
Back Pain: 27 people, 29.67%
Hyperlipidaemia (presence of excess lipids in the blood): 27 people, 29.67%
Loose Tooth: 25 people, 27.47%
Memory Loss: 25 people, 27.47%

What are the existing conditions these people have? *

Depression: 17 people, 18.68%
Nausea (feeling of having an urge to vomit): 17 people, 18.68%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 17 people, 18.68%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 16 people, 17.58%
Sleep Disorder: 16 people, 17.58%
Muscle Spasms (muscle contraction): 16 people, 17.58%
Lung Cancer - Non-Small Cell (lung cancer): 13 people, 14.29%
Bladder Cancer: 7 people, 7.69%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 3.30%
Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 3.30%

* Approximation only. Some reports may have incomplete information.

Do you take Gemzar and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemzar:

Gemzar (20,315 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Gemzar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,340 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,028 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemcitabine hydrochloride (the active ingredients of Gemzar) and Gemzar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.